Merck & Co.
Search results
Organon, here for her health. We are a global healthcare company with a portfolio of therapies and products in women’s health, biosimilars, and established brands across a wide array of conditions and diseases.
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine , contraception , psychiatry , hormone replacement therapy (HRT), and anesthesia .
We show up every day to turn the promise of Organon into a reality. We’re called to create what has been missing in women’s healthcare and are dedicated to improving everyday health for women around the world.
Organon is a global health company that provides ingenious solutions to improve women’s lives.
Mar 11, 2020 · Fueled by its leading contraceptives and fertility businesses, Organon will invest in innovations that support the distinct health care needs of women today.
May 7, 2021 · Organon will be a global healthcare company formed through a spinoff from Merck to focus on improving the health of women throughout their lives. It will have a portfolio of more than 60 medicines and products that help address a spectrum of conditions women face.
Jun 3, 2021 · KENILWORTH, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced it has completed the spinoff of Organon & Co. (Organon).
Jun 3, 2021 · Mumbai, India, June 3 – Organon, today celebrates its launch as the only global company of its size focused on women’s health. With the mission to deliver impactful medicines and solutions, Organon will focus its efforts on building a healthier every day for every woman.
Organon is a global healthcare company with a portfolio of therapies and products in women’s health, biosimilars, and established medicines across a wide array of conditions and diseases. Our...
Jun 15, 2021 · The Edge says Organon will become a major player in the women's health space (with leading contraceptive and fertility products), on top of benefiting from the highly profitable portfolio of ...
